Sirolimus and Cyclosporine for Treatment-Resistant Aplastic Anemia

NCT00319878 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

52

Enrollment

NIH

Sponsor class

Conditions

Anemia, Aplastic

Interventions

DRUG: Sirolimus
DRUG: Cyclosporine

Sponsor

Office of Rare Diseases (ORD)

Collaborators

[object Object]